We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Acoustic Angiography Has Potential to Be Fast, Inexpensive Cancer Diagnosis Tool

By HospiMedica International staff writers
Posted on 12 Jul 2012
In the body, following the twists and turns of blood vessels is complicated, but important. More...
Vessel “bendiness” can indicate the presence and progression of cancer. This tenet has led scientists to a new way of using a high-resolution ultrasound to identify early tumors in preclinical studies. The technology, based on vessel bendiness (tortuosity), has the potential to provide an inexpensive, noninvasive, and quick way to identify cancer that could someday help clinicians identify cancers when tumors are less than 1 cm in size.

The researchers, from University of North Carolina (UNC; Chapel Hill, USA), published their findings were published online July 6, 2012, in the journal Radiology. Paul Dayton, PhD, associate professor of biomedical engineering, explained, “The correlation between vessel tortuosity and cancer is well-established. What’s new about our finding is that we can visualize these vessels in minutes with a very quick scan, using very inexpensive imaging methods.”

The UNC team used a new high-resolution ultrasound method, called “acoustic angiography,” with an intravascular contrast agent that allowed them to acquire images of only the blood vessels. “Unlike current clinical grayscale ultrasound, this method filters out all tissue signals, so we can see small blood vessels clearly,” said Dr. Dayton. “Our results showed a definitive difference between vessels within and surrounding tumors versus those associated with normal healthy vasculature. The limitation that we must now address is that our method works only for tumors at a shallow depth into tissue, such as melanomas or thyroid cancer. Our next studies will focus on this imaging-depth issue as well as evaluating the ability of this technology to determine a tumor’s response to therapy.”

Dr. Dayton further reported that he and his colleagues knew from several clinical and preclinical MRI studies at UNC by Elizabeth Bullitt, MD, and others, and at other institutions that vessels can unbend, or “normalize,” in response to effective therapy. He stressed that clinicians need to see if this inexpensive ultrasound-based method of blood vessel visualization and tortuosity analysis can detect this normalization prior to traditional evaluations of tumor response to therapy, such as measurements of tumor size.

Related Links:

University of North Carolina




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Adhesive
MED 5570U
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.